Fatty acid transport protein 2 reprograms neutrophils in cancer-Reference-Cited by-同舟云学术

Fatty acid transport protein 2 reprograms neutrophils in cancer

Published:2019-04-17 Issue:7754 Volume:569 Page:73-78
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Veglia Filippo,Tyurin Vladimir A.,Blasi Maria,De Leo Alessandra,Kossenkov Andrew V.,Donthireddy Laxminarasimha,To Tsun Ki Jerrick,Schug Zach,Basu Subhasree,Wang Fang,Ricciotti Emanuela,DiRusso Concetta,Murphy Maureen E.,Vonderheide Robert H.,Lieberman Paul M.,Mulligan Charles,Nam Brian,Hockstein Neil,Masters Gregory,Guarino Michael,Lin Cindy,Nefedova Yulia,Black Paul,Kagan Valerian E.,Gabrilovich Dmitry I.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1118-2.pdf

Reference36 articles.

1. Zhou, J., Nefedova, Y., Lei, A. & Gabrilovich, D. Neutrophils and PMN-MDSC: their biological role and interaction with stromal cells. Semin. Immunol. 35, 19–28 (2018).

2. Veglia, F., Perego, M. & Gabrilovich, D. Myeloid-derived suppressor cells coming of age. Nat. Immunol. 19, 108–119 (2018).

3. Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253–268 (2012).

4. Kumar, V., Patel, S., Tcyganov, E. & Gabrilovich, D. I. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 37, 208–220 (2016).

5. Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709–721 (2013).

Cited by 462 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAPK signaling pathway induced LOX-1+ polymorphonuclear myeloid-derived suppressor cells in biliary atresia;Clinical Immunology;2024-11

2. Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis;International Immunopharmacology;2024-10

3. Neutrophils’ dual role in cancer: from tumor progression to immunotherapeutic potential;International Immunopharmacology;2024-10

4. Immunometabolism in cancer: A journey into innate and adaptive cells;International Reviews of Immunology;2024-09-12

5. Dual Oxygen‐Supply Immunosuppression‐Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid‐Derived Suppressor Cells;Small;2024-09-05